Your browser doesn't support javascript.
loading
Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.
Gao, Xiaoge; Jiang, Pin; Wei, Xiaohuan; Zhang, Wei; Zheng, Jiwei; Sun, Shishuo; Yao, Hong; Liu, Xiangye; Zhang, Qing.
Afiliación
  • Gao X; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Jiang P; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Wei X; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Zhang W; Nanjing International Hospital Co., Ltd, Nanjing, Jiangsu Province, 210000, People's Republic of China.
  • Zheng J; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Sun S; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Yao H; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
  • Liu X; Medical Oncology of Huangmei People's Hospital, Huanggang, Hubei Province, 435500, People's Republic of China.
  • Zhang Q; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, People's Republic of China.
BMC Cancer ; 23(1): 359, 2023 Apr 19.
Article en En | MEDLINE | ID: mdl-37076852

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article